Citigroup Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $650.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target cut by Citigroup from $700.00 to $650.00 in a research note released on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of a number of other research reports. JPMorgan Chase & Co. cut their price […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target cut by Citigroup from $700.00 to $650.00 in a research note released on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of a number of other research reports. JPMorgan Chase & Co. cut their price […]
